A year after private equity-backed Noble Health shuttered two rural Missouri hospitals, a slew of lawsuits and state and federal investigations grind forward. Missouri Attorney General Andrew Bailey recently confirmed an “ongoing” investigation as former employees continue to go unpaid and cope with unpaid medical claims.
The May 11 expiration of the federal government’s pandemic emergency declaration will affect patient care across a broad range of settings, including telemedicine, hospitals, and nursing homes.
In-person mental health care is hard to arrange in rural nursing homes, so video chats with faraway professionals are filling the gap.
A U.S. District Court case is being widely followed because the judge’s decision could overturn the FDA’s approval of mifepristone two decades ago. With abortion rights polling well even in red states, anti-abortion activists are increasingly turning to the courts to achieve their aims.
Mobile clinics that provided covid-19 testing and vaccines at the peak of the pandemic are now being used to provide a range of health services in hard-to-reach communities. A law passed late last year allows qualified health care centers to use federal grants to expand the fleets.
Gov. Gavin Newsom, who blasted pharmaceutical companies for gouging Californians, is moving ahead with state-branded insulin. He’s also eyeing other generic drugs.
A state law says giving false information to patients about covid-19 constitutes unprofessional conduct for which regulators can discipline doctors. Vaccine skeptics, including Robert F. Kennedy Jr., join civil liberties groups and others in arguing that it violates free speech.
Any day now a conservative federal judge in Texas could upend the national abortion debate by requiring the FDA to rescind its approval of mifepristone, a drug approved in the U.S. more than 20 years ago that is now used in more than half of abortions nationwide. Meanwhile, a controversial study on masks gets a clarification, although it may be too late to change the public impression of what it found. Alice Miranda Ollstein of Politico, Jessie Hellmann of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
The FDA’s interest in the AGGA dental device follows a KHN-CBS News investigation, according to a former agency official.
The federal government wants to change the way health insurers use prior authorization — the requirement that patients get permission before undergoing treatment. Designed to prevent doctors from deploying expensive, ineffectual procedures, prior authorization has morphed into an unwieldy monster that denies or delays care, burdens physicians with paperwork, and perpetuates racial disparities. New federal rules may not be enough to tame it.
